Effect of olive leaves extract on the antidiabetic effect of glyburide for possible herb-drug interaction

Maged S Abdel-Kader; Gamal A Soliman; Rehab F Abdel-Rahman; Abdulaziz S Saeedan; Reham M Abd-Elsalam; Hanan A Ogaly

doi:10.1016/j.jsps.2019.10.001

Effect of olive leaves extract on the antidiabetic effect of glyburide for possible herb-drug interaction

Saudi Pharm J. 2019 Dec;27(8):1182-1195. doi: 10.1016/j.jsps.2019.10.001. Epub 2019 Oct 11.

Authors

Maged S Abdel-Kader^{1

2}, Gamal A Soliman^{3

4}, Rehab F Abdel-Rahman⁵, Abdulaziz S Saeedan³, Reham M Abd-Elsalam⁶, Hanan A Ogaly^{7

8}

Affiliations

¹ Department of Pharmacognosy, College of Pharmacy, Prince Sattam bin Abdulaziz University, P.O. Box 173, Al-Kharj 11942, Saudi Arabia.
² Department of Pharmacognosy, College of Pharmacy, Alexandria University, Alexandria 21215, Egypt.
³ Department of Pharmacology, College of Pharmacy, Prince Sattam bin Abdulaziz University, P.O. Box 173, Al-Kharj 11942, Saudi Arabia.
⁴ Department of Pharmacology, College of Veterinary Medicine, Cairo University, Giza, Egypt.
⁵ Department of Pharmacology, National Research Centre, Giza, Egypt.
⁶ Department of Pathology, College of Veterinary Medicine, Cairo University, Giza, Egypt.
⁷ Department of Chemistry, College of Science, King Khalid University, Abha, Saudi Arabia.
⁸ Department of Biochemistry, College of Veterinary Medicine, Cairo University, Giza, Egypt.

Abstract

The concomitant use of olive leaves (OL) and glyburide (GLB) is a possible therapy for diabetic patients. However, there is no report about the effect of OL on the antidiabetic effect of GLB till now. In the current study, the possible interaction of olive leaves extract (OLE) with GLB was assessed to determine if there was any pharmacological benefit over GLB alone. Seven groups of male Sprague Dawley rats were used. Normal rats of the 1st group treated with 2 mL/kg of 3% Tween 80 (vehicle). The 2nd-5th groups were diabetic rats received vehicle, GLB (5 mg/kg), OLE low dose and OLE high dose respectively, while the 6th-7th groups administered combinations of GLB plus OLE low dose and GLB plus OLE high dose, respectively. All treatments were administered orally once daily for 8 weeks. The use of GLB+OLE-500 obviously improved fasting blood glucose (FBG), insulin and glycated hemoglobin (HbA1c) in diabetic rats (95.5 ± 5.55 mg/dL, 6.8 ± 0.16 mg/dL and 6.1 ± 0.29%, respectively) compared to those treated with GLB monotherapy (140.0 ± 6.36 mg/dL, 5.4 ± 0.19 mg/dL and 7.0 ± 0.20%, respectively). The lipid profile [triglycerides (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C)] was significantly improved in diabetic rats exposed to GLB+OLE-500 (35.6 ± 1.51 mg/dL, 48.5 ± 2.74 mg/dL, 25.1 ± 1.21 mg/dL and 17.0 ± 0.82 mg/dL, respectively) in comparison with diabetic group exposed to GLB alone (43.2 ± 2.15 mg/dL, 56.8 ± 2.14 mg/dL, 18.6 ± 0.96 mg/dL, 23.0 ± 1.26 mg/dL, respectively). Additionally, the benefit impacts of GLB+OLE-500GLB+OLE-500 therapy on the antioxidant and lipid peroxidation parameters in the pancreatic tissues of diabetic rats were higher than those of GLB monotherapy. Moreover, GLB plus OLE-500 combination had the greatest effect on restoration of the insulin content of Beta (β) cells and reduction of the glucagon and somatostatin of Alpha (α) and Delta (δ) endocrine cells in the pancreatic islets among the different treatment. The current study suggests that OL and GLB combination could cause herb-drug interactions through modulation of insulin receptor (INR), glucose transporter 2 (Slc2a2) and peroxisome proliferator-activated receptor α (PPAR-α) genes expression in the liver of diabetic rats.

Keywords: Glyburide; INR; Olea europaea; PPAR-α; Rat; Slc2a2; Streptozotocin.